The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanagawa, O.
Right arrow Articles by Vaupel, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanagawa, O.
Right arrow Articles by Vaupel, B. A.
The Journal of Immunology, 2000, 164: 3919-3923.
Copyright © 2000 by The American Association of Immunologists

Protection of Nonobese Diabetic Mice from Diabetes by Gene(s) Closely Linked to IFN-{gamma} Receptor Loci1

Osami Kanagawa2, Guan Xu, Amye Tevaarwerk and Barbara A. Vaupel

Center for Immunology and Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110

Nonobese diabetic (NOD) mice carrying a segment of chromosome flanking the disrupted IFN-{gamma} receptor gene from original 129 ES cells are resistant to development of diabetes. However, extended backcrossing of this mouse line to the NOD mouse resulted in a segregation of the IFN-{gamma}R-deficient genotype from the diabetes-resistant phenotype. These results indicate that the protection of NOD mice from the development of diabetes is not directly linked to the defective IFN-{gamma} receptor gene but, rather, is influenced by the presence of a diabetes-resistant gene(s) closely linked to the IFN-{gamma}R loci derived from the 129 mouse strain.




This article has been cited by other articles:


Home page
 Int ImmunolHome page
Y. Mori, T. Kodaka, T. Kato, E. M. Kanagawa, and O. Kanagawa
Critical role of IFN-{gamma} in CFA-mediated protection of NOD mice from diabetes development
Int. Immunol., November 1, 2009; 21(11): 1291 - 1299.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Kamanaka, D. Rainbow, K. Schuster-Gossler, E. E. Eynon, A. V. Chervonsky, L. S. Wicker, and R. A. Flavell
Amino acid polymorphisms altering the glycosylation of IL-2 do not protect from type 1 diabetes in the NOD mouse
PNAS, July 7, 2009; 106(27): 11236 - 11240.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. H. Esensten, M. R. Lee, L. H. Glimcher, and J. A. Bluestone
T-bet-Deficient NOD Mice Are Protected from Diabetes Due to Defects in Both T Cell and Innate Immune System Function
J. Immunol., July 1, 2009; 183(1): 75 - 82.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. H. Leiter, P. C. Reifsnyder, R. Wallace, R. Li, B. King, and G. C. Churchill
NOD x 129.H2g7 Backcross Delineates 129S1/SvImJ-Derived Genomic Regions Modulating Type 1 Diabetes Development in Mice
Diabetes, July 1, 2009; 58(7): 1700 - 1703.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. K. Turner, J. L. Xu, and R. I. Tapping
Substrains of 129 Mice Are Resistant to Yersinia pestis KIM5: Implications for Interleukin-10-Deficient Mice
Infect. Immun., January 1, 2009; 77(1): 367 - 373.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Calderon, A. Suri, X. O. Pan, J. C. Mills, and E. R. Unanue
IFN-{gamma}-Dependent Regulatory Circuits in Immune Inflammation Highlighted in Diabetes
J. Immunol., November 15, 2008; 181(10): 6964 - 6974.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
Y. Mori, T. Kato, T. Kodaka, E. M. Kanagawa, S. Hori, and O. Kanagawa
Protection of IFN-{gamma} signaling-deficient NOD mice from diabetes by cyclophosphamide
Int. Immunol., September 1, 2008; 20(9): 1231 - 1237.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Duffy, S. M. Sparshott, C.-p. Yang, and E. B. Bell
Transgenic CD4 T Cells (DO11.10) Are Destroyed in MHC-Compatible Hosts by NK Cells and CD8 T Cells
J. Immunol., January 15, 2008; 180(2): 747 - 753.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. A. Cain, J. A. Smith, J. K. Ondr, B. Wang, and J. D. Katz
NKT Cells and IFN-{gamma} Establish the Regulatory Environment for the Control of Diabetogenic T Cells in the Nonobese Diabetic Mouse
J. Immunol., February 1, 2006; 176(3): 1645 - 1654.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. A. Salam, K. Matin, N. Matsumoto, Y. Tsuha, N. Hanada, and H. Senpuku
E2f1 Mutation Induces Early Onset of Diabetes and Sjogren's Syndrome in Nonobese Diabetic Mice
J. Immunol., October 15, 2004; 173(8): 4908 - 4918.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Matos, R. Park, D. Mathis, and C. Benoist
Progression to Islet Destruction in a Cyclophosphamide-Induced Transgenic Model: A Microarray Overview
Diabetes, September 1, 2004; 53(9): 2310 - 2321.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Sarween, A. Chodos, C. Raykundalia, M. Khan, A. K. Abbas, and L. S. K. Walker
CD4+CD25+ Cells Controlling a Pathogenic CD4 Response Inhibit Cytokine Differentiation, CXCR-3 Expression, and Tissue Invasion
J. Immunol., September 1, 2004; 173(5): 2942 - 2951.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. M. W. Chong, Y. Chen, R. Darwiche, N. L. Dudek, W. Irawaty, P. Santamaria, J. Allison, T. W. H. Kay, and H. E. Thomas
Suppressor of Cytokine Signaling-1 Overexpression Protects Pancreatic {beta} Cells from CD8+ T Cell-Mediated Autoimmune Destruction
J. Immunol., May 1, 2004; 172(9): 5714 - 5721.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. M. Esteban, T. Tsoutsman, M. A. Jordan, D. Roach, L. D. Poulton, A. Brooks, O. V. Naidenko, S. Sidobre, D. I. Godfrey, and A. G. Baxter
Genetic Control of NKT Cell Numbers Maps to Major Diabetes and Lupus Loci
J. Immunol., September 15, 2003; 171(6): 2873 - 2878.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Cenci, G. Toraldo, M. N. Weitzmann, C. Roggia, Y. Gao, W. P. Qian, O. Sierra, and R. Pacifici
Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-{gamma}-induced class II transactivator
PNAS, September 2, 2003; 100(18): 10405 - 10410.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Trembleau, G. Penna, S. Gregori, N. Giarratana, and L. Adorini
IL-12 Administration Accelerates Autoimmune Diabetes in Both Wild-Type and IFN-{gamma}-Deficient Nonobese Diabetic Mice, Revealing Pathogenic and Protective Effects of IL-12-Induced IFN-{gamma}
J. Immunol., June 1, 2003; 170(11): 5491 - 5501.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. V. Serreze, M. A. Pierce, C. M. Post, H. D. Chapman, H. Savage, R. T. Bronson, P. B. Rothman, and G. A. Cox
Paralytic Autoimmune Myositis Develops in Nonobese Diabetic Mice Made Th1 Cytokine-Deficient by Expression of an IFN-{gamma} Receptor {beta}-Chain Transgene
J. Immunol., March 1, 2003; 170(5): 2742 - 2749.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Minamino, T. Yujiri, N. Terada, G. E. Taffet, L. H. Michael, G. L. Johnson, and M. D. Schneider
MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq
PNAS, March 19, 2002; 99(6): 3866 - 3871.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. R. Potter, S. R. Rittling, D. T. Denhardt, R. J. Roper, J. H. Weis, C. Teuscher, and J. J. Weis
Role of Osteopontin in Murine Lyme Arthritis and Host Defense against Borrelia burgdorferi
Infect. Immun., March 1, 2002; 70(3): 1372 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. E. Thomas, R. Darwiche, J. A. Corbett, and T. W.H. Kay
Interleukin-1 Plus {gamma}-Interferon-Induced Pancreatic {beta}-Cell Dysfunction Is Mediated by {beta}-Cell Nitric Oxide Production
Diabetes, February 1, 2002; 51(2): 311 - 316.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. M.W. Chong, H. E. Thomas, and T. W.H. Kay
{gamma}-Interferon Signaling in Pancreatic {beta}-Cells Is Persistent but Can Be Terminated by Overexpression of Suppressor of Cytokine Signaling-1
Diabetes, December 1, 2001; 50(12): 2744 - 2751.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Y. Savinov, F. S. Wong, and A. V. Chervonsky
IFN-{gamma} Affects Homing of Diabetogenic T Cells
J. Immunol., December 1, 2001; 167(11): 6637 - 6643.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. P.L. Chiu, D. V. Serreze, and J. S. Danska
Development and Function of Diabetogenic T-cells in B-cell-Deficient Nonobese Diabetic Mice
Diabetes, April 1, 2001; 50(4): 763 - 770.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
D. V. Serreze, H. D. Chapman, C. M. Post, E. A. Johnson, W. L. Suarez-Pinzon, and A. Rabinovitch
Th1 to Th2 Cytokine Shifts in Nonobese Diabetic Mice: Sometimes an Outcome, Rather Than the Cause, of Diabetes Resistance Elicited by Immunostimulation
J. Immunol., January 15, 2001; 166(2): 1352 - 1359.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. L. Radu, N. Noben-Trauth, J. Hu-Li, W. E. Paul, and C. A. Bona
A targeted mutation in the IL-4Ralpha gene protects mice against autoimmune diabetes
PNAS, November 7, 2000; 97(23): 12700 - 12704.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.